Meanwhile, following EMPA treatment, Nrf1 upregulation enhanced SIRT7 signaling pathway activation, protected against lipid deposition-related metabolic disorders, and inhibited lipogenesis and oxidative stress. The gene discussed is NRF1; the disease is metabolic disease.